DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
86.04
-1.67 (-1.90%)
At close: Oct 16, 2026, 4:00 PM EDT
85.68
-0.36 (-0.42%)
After-hours: Oct 16, 2026, 7:34 PM EDT
DexCom Market Cap
DexCom has a market cap or net worth of $32.47 billion as of October 16, 2026. It is the 758th most valuable company in the world and the 340th biggest in the United States. Its market cap has increased by 26.58% in one year.
Market Cap
32.47B
Enterprise Value
31.92B
1-Year Change
26.58%
Global Rank
Country Rank
#340 United States
Category
ChartMarket Cap Chart
Since April 14, 2005, DexCom's market cap has increased from $312.50M to $32.47B, an increase of 10,289.80%. That is a compound annual growth rate of 24.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 32.47B | 25.43% |
| Dec 31, 2025 | 25.89B | -14.79% |
| Dec 31, 2024 | 30.38B | -36.64% |
| Dec 29, 2023 | 47.95B | 9.61% |
| Dec 30, 2022 | 43.74B | -15.95% |
| Dec 31, 2021 | 52.04B | 46.58% |
| Dec 31, 2020 | 35.50B | 77.33% |
| Dec 31, 2019 | 20.02B | 88.10% |
| Dec 31, 2018 | 10.64B | 113.41% |
| Dec 29, 2017 | 4.99B | -1.16% |
| Dec 30, 2016 | 5.05B | -24.21% |
| Dec 31, 2015 | 6.66B | 57.98% |
| Dec 31, 2014 | 4.21B | 65.82% |
| Dec 31, 2013 | 2.54B | 169.96% |
| Dec 31, 2012 | 941.50M | 49.75% |
| Dec 30, 2011 | 628.70M | -21.59% |
| Dec 31, 2010 | 801.80M | 115.77% |
| Dec 31, 2009 | 371.60M | 352.07% |
| Dec 31, 2008 | 82.20M | -67.11% |
| Dec 31, 2007 | 249.90M | -9.82% |
| Dec 29, 2006 | 277.10M | -26.81% |
| Dec 30, 2005 | 378.60M | 21.15% |
| Apr 14, 2005 | 312.50M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Boston Scientific | 63.97B |
| Edwards Lifesciences | 50.78B |
| GE HealthCare Technologies | 31.78B |
| Koninklijke Philips | 24.88B |
| STERIS | 21.87B |
| Zimmer Biomet Holdings | 18.00B |
| Penumbra | 12.65B |
| Smith & Nephew | 12.13B |